Pre-eclampsia is a life-threatening disease of pregnancy unique to humans and a leading
cause of maternal and neonatal morbidity and mortality. Women who survive pre-eclampsia …

Preeclampsia Preeclampsia complicates 2 to 4% of all pregnancies and accounts for about
46,000 maternal deaths and 500,000 fetal or newborn deaths each year. Antihypertensive …

Preeclampsia (PE) is a leading cause for peripartal morbidity, especially if developing early
in gestation. To enable prophylaxis in the prevention of PE, pregnancies at risk of PE must …

Background: Effective screening for term preeclampsia is provided by a combination of
maternal factors with measurements of mean arterial pressure, serum placental growth …

Abstract Purpose of Review Hypertensive disorders of pregnancy (HDP)—gestational
hypertension, preeclampsia, and eclampsia—are a leading cause of adverse maternal and …

Background Calcium supplementation reduces the risk of pre‐eclampsia, but questions
remain about the dosage to prescribe and who would benefit most. Objectives To evaluate …

Background Early prediction of preeclampsia is challenging because of poorly understood
causes, various risk factors, and likely multiple pathogenic phenotypes of preeclampsia …

Preeclampsia, a multisystem disorder in pregnancy, is still one of the main causes of
maternal morbidity and mortality. Due to a lack of a causative therapy, an accurate prediction …

Preeclampsia is a complex disease of pregnancy whose physiopathology remains unclear.
We developed machine-learning models for early prediction of preeclampsia (first 16 weeks …

Objective To elucidate whether pre‐eclampsia (PE) and the gestational age at onset of the
disease (early‐vs late‐onset PE) have an impact on the risk of long‐term maternal …